NEWS
Jun 23, 2022
Actimed Therapeutics to present on development of its lead asset in treatment of cancer cachexia at the Society on Sarcopenia, Cachexia and Wasting Disorders
Read more>>>
May 4, 2022
Actimed Therapeutics secures significant new patent, extending IP coverage of its lead compound for use in key indication
Read more>>>
Management Team and Board

David Ebsworth

Chairman

Robin Bhattacherjee

Chief Executive Officer

Andrew J. Stewart Coats

Founder and Non-Executive Director

Frank Misselwitz

Chief Medical Officer and Non-executive Director

Stefan Wohlfeil

Non-executive Director

Hugh Jackson

Chief Financial Officer

Pipeline